Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Penumbra (PEN) Research & Development (2016 - 2025)

Penumbra (PEN) has disclosed Research & Development for 12 consecutive years, with $21.8 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 8.92% to $21.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89.8 million through Dec 2025, down 5.29% year-over-year, with the annual reading at $89.8 million for FY2025, 5.29% down from the prior year.
  • Research & Development for Q4 2025 was $21.8 million at Penumbra, down from $22.7 million in the prior quarter.
  • The five-year high for Research & Development was $52.0 million in Q4 2021, with the low at $16.7 million in Q3 2021.
  • Average Research & Development over 5 years is $22.6 million, with a median of $21.4 million recorded in 2022.
  • The sharpest move saw Research & Development surged 167.3% in 2021, then crashed 65.46% in 2022.
  • Over 5 years, Research & Development stood at $52.0 million in 2021, then tumbled by 65.46% to $18.0 million in 2022, then increased by 22.14% to $21.9 million in 2023, then decreased by 8.81% to $20.0 million in 2024, then grew by 8.92% to $21.8 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $21.8 million, $22.7 million, and $23.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.